OcaB is required for normal transcription and V(D)J recombination of a subset of immunoglobulin κ genes

Cell

Volumn 110, Issue 5, 2002, Pages 575-585

  Casellas, Rafael ^a   Jankovic, Mila ^a   Meyer, Gesa ^a   Gazumyan, Anna ^a   Luo, Yan ^a   Roeder, Robert G ^a   Nussenzweig, Michel C ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; GENETIC ANALYSIS; GENETIC PROCEDURES; GENETIC RECOMBINATION; GENETIC TRANSCRIPTION; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALIA; EUKARYOTA;

EID: 0037031604     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)00911-X     Document Type: Article

References (57)

1. Aranburu A., Carlsson R., Persson C., Leanderson T. Transcription factor AP-4 is a ligand for immunoglobulin-kappa promoter E-box elements. Biochem. J. 354:2001;431-438.
2. Bemark M., Liberg D., Leanderson T. Conserved sequence elements in K promoters from mice and humans. implications for transcriptional regulation and repertoire expression Immunogenetics. 47:1998;183-195. a.
3. Bemark M., Olsson H., Heinegard D., Leanderson T. Purification and characterization of a protein binding to the SP6 kappa promoter. A potential role for CArG-box binding factor-A in kappa transcription. J. Biol. Chem. 273:1998;18881-18890. b.
4. Blackwell T.K., Moore M.W., Yancopoulos G.D., Suh H., Lutzker S., Selsing E., Alt F.W. Recombination between immunoglobulin variable region gene segments is enhanced by transcription. Nature. 324:1986;585-589.
5. Casellas R., Shih T.A., Kleinewietfeld M., Rakonjac J., Nemazee D., Rajewsky K., Nussenzweig M.C. Contribution of receptor editing to the antibody repertoire. Science. 291:2001;1541-1544.
6. Chasman D., Cepek K., Sharp P.A., Pabo C.O. Crystal structure of an OCA-B peptide bound to an Oct-1 POU domain/octamer DNA complex. specific recognition of a protein-DNA interface Genes Dev. 13:1999;2650-2657.
7. Chen J., Young F., Bottaro A., Stewart V., Smith R.K., Alt F.W. Mutations of the intronic IgH enhancer and its flanking sequences differentially affect accessibility of the JH locus. EMBO J. 12:1993;4635-4645.
8. Chen C., Prak E.L., Weigert M. Editing disease-associated autoantibodies. Immunity. 6:1997;97-105.
9. Corcoran A.E., Riddell A., Krooshoop D., Venkitaraman A.R. Impaired immunoglobulin gene rearrangement in mice lacking the IL-7 receptor. Nature. 391:1998;904-907.
10. Dreyfus M., Doyen N., Rougeon F. The conserved decanucleotide from the immunoglobulin heavy chain promoter induces a very high transcriptional activity in B-cells when introduced into an heterologous promoter. EMBO J. 6:1987;1685-1690.
11. Engler P., Weng A., Storb U. Influence of CpG methylation and target spacing on V(D)J recombination in a transgenic substrate. Mol. Cell. Biol. 13:1993;571-577.
12. Franke S., Scholz G., Scheidereit C. Identification of novel ubiquitous and cell type-specific factors that specifically recognize immunoglobulin heavy chain and kappa light chain promoters. J. Biol. Chem. 269:1994;20075-20082.
13. Gay D., Saunders T., Camper S., Weigert M. Receptor editing. an approach by autoreactive B cells to escape tolerance J. Exp. Med. 177:1993;999-1008.
14. Gonzalgo M.L., Jones P.A. Rapid quantitation of methylation differences at specific sites using methylation-sensitive single nucleotide primer extension (Ms-SnupPE). Nucleic Acids Res. 25:1997;2529-2531.
15. Goodnow C.C., Crosbie J., Adelstein S., Lavoie T.B., Smith-Gill S.J., Brink R.A., Pritchard-Briscoe H., Wotherspoon J.S., Loblay R.H., Raphael K.et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature. 334:1988;676-682.
16. Greiner A., Muller K.B., Hess J., Pfeffer K., Muller-Hermelink H.K., Wirth T. Up-regulation of BOB.1/OBF.1 expression in normal germinal center B cells and germinal center-derived lymphomas. Am. J. Pathol. 156:2000;501-507.
17. Grunstein M. Histone acetylation in chromatin structure and transcription. Nature. 389:1997;349-352.
18. Gstaiger M., Knoepfel L., Georgiev O., Schaffner W., Hovens C.M. A B-cell coactivator of octamer-binding transcription factors. Nature. 373:1995;360-362.
19. Gstaiger M., Georgiev O., van Leeuwen H., van der Vliet P., Schaffner W. The B cell coactivator Bob1 shows DNA sequence-dependent complex formation with Oct-1/Oct-2 factors, leading to differential promoter activation. EMBO J. 15:1996;2781-2790.
20. Kim U., Qin X.F., Gong S., Stevens S., Luo Y., Nussenzweig M., Roeder R.G. The B-cell-specific transcription coactivator OCA-B/OBF-1/Bob-1 is essential for normal production of immunoglobulin isotypes. Nature. 383:1996;542-547.
21. Kwon J., Morshead K.B., Guyon J.R., Kingston R.E., Oettinger M.A. Histone acetylation and hSWI/SNF remodeling act in concert to stimulate V(D)J cleavage of nucleosomal DNA. Mol. Cell. 6:2000;1037-1048.
22. LaBella F., Sive H.L., Roeder R.G., Heintz N. Cell-cycle regulation of a human histone H2b gene is mediated by the H2b subtype-specific consensus element. Genes Dev. 2:1988;32-39.
23. Luo Y., Roeder R.G. Cloning, functional characterization, and mechanism of action of the B-cell-specific transcriptional coactivator OCA-B. Mol. Cell. Biol. 15:1995;4115-4124.
24. Luo Y., Fujii H., Gerster T., Roeder R.G. A novel B cell-derived coactivator potentiates the activation of immunoglobulin promoters by octamer-binding transcription factors. Cell. 71:1992;231-241.
25. McMurry M.T., Krangel M.S. A role for histone acetylation in the developmental regulation of VDJ recombination. Science. 287:2000;495-498.
26. Nemazee D.A., Burki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337:1989;562-566.
27. Nielsen P.J., Georgiev O., Lorenz B., Schaffner W. B lymphocytes are impaired in mice lacking the transcriptional co-activator Bob1/OCA-B/OBF1. Eur. J. Immunol. 26:1996;3214-3218.
28. Nussenzweig M.C. Immune receptor editing. revise and select Cell. 95:1998;875-878.
29. Parry H.D., Scherly D., Mattaj I.W. "Snurpogenesis" the transcription and assembly of U snRNP components Trends Biochem. Sci. 14:1989;15-19.
30. Pelletier M.R., Hatada E.N., Scholtz G., Scheidereit C. Efficient transcription of an immunoglobulin kappa promoter requires specific sequence elements overlapping with and downstream of the transcriptional start site. Nucleic Acids Res. 25:1997;3995-4003.
31. Pierani A. Activation of octamer-containing promoters by either octamer-binding transcription factor 1 (OTF-1) or OTF-2 and requirement of an additional B-cell-specific component for optimal transcription of immunoglobulin promoters. Mol. Cell. Biol. 10:1990;6204-6215.
32. Prak E.L., Weigert M. Light chain replacement. a new model for antibody gene rearrangement J. Exp. Med. 182:1995;541-548.
33. Qin X.F., Reichlin A., Luo Y., Roeder R.G., Nussenzweig M.C. OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development. EMBO J. 17:1998;5066-5075.
34. Remenyi A., Tomilin A., Pohl E., Lins K., Philippsen A., Reinbold R., Scholer H.R., Wilmanns M. Differential dimer activities of the transcription factor Oct-1 by DNA-induced interface swapping. Mol. Cell. 8:2001;569-580.
35. Retter M.W., Nemazee D. Receptor editing occurs frequently during normal B cell development. J. Exp. Med. 188:1998;1231-1238.
36. Romanow W.J. E2A and EBF act in synergy with the V(D)J recombinase to generate a diverse immunoglobulin repertoire in nonlymphoid cells. Mol. Cell. 5:2000;343-353.
37. Sauter P., Matthias P. Coactivator OBF-1 makes selective contacts with both the POU-specific domain and the POU homeodomain and acts as a molecular clamp on DNA. Mol. Cell. Biol. 18:1998;7397-7409.
38. Schlissel M.S., Baltimore D. Activation of immunoglobulin kappa gene rearrangement correlates with induction of germline kappa gene transcription. Cell. 58:1989;1001-1007.
39. Schubart D.B., Rolink A., Kosco-Vilbois M.H., Botteri F., Matthias P. B-cell-specific coactivator OBF-1/OCA-B/Bob1 required for immune response and germinal centre formation. Nature. 383:1996;538-542. a.
40. Schubart D.B., Sauter P., Massa S., Friedl E.M., Schwarzenbach H., Matthias P. Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1. Nucleic Acids Res. 24:1996;1913-1920. b.
41. Schubart D.B., Rolink A., Schubart K., Matthias P. Cutting edge. lack of peripheral B cells and severe agammaglobulinemia in mice simultaneously lacking Bruton's tyrosine kinase and the B cell-specific transcriptional coactivator OBF-1 J. Immunol. 164:2000;18-22.
42. Schubart K., Massa S., Schubart D., Corcoran L.M., Rolink A.G., Matthias P. B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1. Nat. Immunol. 2:2001;69-74.
43. Schwarzenbach H., Newell J.W., Matthias P. Involvement of the Ets family factor PU.1 in the activation of immunoglobulin promoters. J. Biol. Chem. 270:1995;898-907.
44. Serwe M., Sablitzky F. V(D)J recombination in B cells is impaired but not blocked by targeted deletion of the immunoglobulin heavy chain intron enhancer. EMBO J. 12:1993;2321-2327.
45. Sigvardsson M., Bemark M., Leanderson T. Pentadecamer-binding proteins. definition of two independent protein-binding sites needed for functional activity Mol. Cell. Biol. 15:1995;1343-1352.
46. Stanhope-Baker P., Hudson K.M., Shaffer A.L., Constantinescu A., Schlissel M.S. Cell type-specific chromatin structure determines the targeting of V(D)J recombinase activity in vitro. Cell. 85:1996;887-897.
47. Staudt L.M., Lenardo M.J. Immunoglobulin gene transcription. Annu. Rev. Immunol. 9:1991;373-398.
48. Strubin M., Newell J.W., Matthias P. OBF-1, a novel B cell-specific coactivator that stimulates immunoglobulin promoter activity through association with octamer-binding proteins. Cell. 80:1995;497-506.
49. Tantin D., Sharp P.A. Mouse lymphoid cell line selected to have high immunoglobulin promoter activity. Mol. Cell. Biol. 22:2002;1460-1473.
50. Thiebe R., Schable K.F., Bensch A., Brensing-Kuppers J., Heim V., Kirschbaum T., Mitlohner H., Ohnrich M., Pourrajabi S., Roschenthaler F.et al. The variable genes and gene families of the mouse immunoglobulin kappa locus. Eur. J. Immunol. 29:1999;2072-2081.
51. Tiegs S.L., Russell D.M., Nemazee D. Receptor editing in self-reactive bone marrow B cells. J. Exp. Med. 177:1993;1009-1020.
52. Tomilin A., Remenyi A., Lins K., Bak H., Leidel S., Vriend G., Wilmanns M., Scholer H.R. Synergism with the coactivator OBF-1 (OCA-B, BOB-1) is mediated by a specific POU dimer configuration. Cell. 103:2000;853-864.
53. Van Parijs L. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity. 11:1999;763-770.
54. Whitehurst C.E., Schlissel M.S., Chen J. Deletion of germline promoter PD beta 1 from the TCR beta locus causes hypermethylation that impairs D beta 1 recombination by multiple mechanisms. Immunity. 13:2000;703-714.
55. Wirth T., Staudt L., Baltimore D. An octamer oligonucleotide upstream of a TATA motif is sufficient for lymphoid-specific promoter activity. Nature. 329:1987;174-178.
56. Xu Y., Davidson L., Alt F.W., Baltimore D. Deletion of the Ig kappa light chain intronic enhancer/matrix attachment region impairs but does not abolish V kappa J kappa rearrangement. Immunity. 4:1996;377-385.
57. Yancopoulos G.D., Alt F.W. Developmentally controlled and tissue-specific expression of unrearranged VH gene segments. Cell. 40:1985;271-281.